FN1, one of the most abundant glycoproteins in the ECM, is expressed not only in the stroma but also in tumor cells and exerts a significant role in tumor progression, invasion and premetastatic and metastatic disease mainly through integrin-mediated signaling [43–45]. Here, FN1 is linked to metastatic neoplasm.